Editorial, sources and corrections policy
This policy explains how educational content is prepared and how Mighty BioLabs separates evidence summaries from commercial catalogue information.
Who prepares the content
Articles are prepared by the Mighty BioLabs Editorial Team. Where a qualified external reviewer is involved, that person and their verified qualifications will be named on the article. We do not imply anonymous medical or scientific credentials.
Source selection
We prioritize peer-reviewed research, recognized scientific databases, standards organizations, regulator publications and official laboratory documentation. Product pages and marketing claims are not treated as independent scientific evidence.
Evidence and limitations
Articles distinguish established analytical facts from preliminary, model-specific or uncertain findings. We identify important limitations and avoid translating laboratory findings into personal-use, treatment or dosing advice.
Commercial conflict
Mighty BioLabs sells research materials discussed on this website. This is a direct commercial interest. Editorial articles are intended to explain scientific and analytical concepts, and commercial links are kept contextual rather than presented as scientific recommendations.
Corrections and updates
Material corrections are made transparently. Substantive revisions should update the “last reviewed” date and, where useful, include a short revision note. Cosmetic edits do not receive a false freshness date.
To report a factual error or provide a primary source we should review, contact support@mightybiolabs.is with the article URL and the passage in question.
Scope boundary
The Research Library does not provide dosing information, routes of administration, treatment advice, personal-use protocols or instructions for human or veterinary use. Calculator content is limited to researcher-entered mathematical conversions.
Policy published and last reviewed: August 7, 2026.